Drug Shortage Report for KETOROLAC TROMETHAMINE INJECTION USP
| Report ID | 84327 |
| Drug Identification Number | 02390582 |
| Brand name | KETOROLAC TROMETHAMINE INJECTION USP |
| Common or Proper name | Ketorolac |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | KETOROLAC TROMETHAMINE |
| Strength(s) | 30MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 25 x 1 mL vial |
| ATC code | M01AB |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-08-10 |
| Actual start date | |
| Estimated end date | 2019-09-30 |
| Actual end date | 2019-07-12 |
| Shortage status | Avoided shortage |
| Updated date | 2019-07-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-05-17 | English | Compare |
| v2 | 2019-05-17 | French | Compare |
| v3 | 2019-07-12 | English | Compare |
| v4 | 2019-07-12 | French | Compare |
Showing 1 to 4 of 4